0001209191-18-055803.txt : 20181019 0001209191-18-055803.hdr.sgml : 20181019 20181019203736 ACCESSION NUMBER: 0001209191-18-055803 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181018 FILED AS OF DATE: 20181019 DATE AS OF CHANGE: 20181019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Neff Thomas B CENTRAL INDEX KEY: 0001623238 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36740 FILM NUMBER: 181131386 MAIL ADDRESS: STREET 1: C/O FIBROGEN, INC. STREET 2: 409 ILLINOIS ST. CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIBROGEN INC CENTRAL INDEX KEY: 0000921299 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-1200 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-10-18 0 0000921299 FIBROGEN INC FGEN 0001623238 Neff Thomas B C/O FIBROGEN, INC. 409 ILLINOIS ST. SAN FRANCISCO CA 94158 1 1 0 0 Chief Executive Officer Common Stock 2018-10-18 4 M 0 10319 3.60 A 2710412 D Common Stock 2018-10-18 4 S 0 13136 54.23 D 2697276 D Common Stock 2018-10-18 4 S 0 5364 55.13 D 2691912 D Common Stock 2018-10-18 4 S 0 400 55.90 D 2691512 D Common Stock 2018-10-18 4 S 0 718 54.36 D 94076 I By Family Partnership Common Stock 2018-10-18 4 S 0 200 55.29 D 93876 I By Family Partnership Common Stock 2018-10-19 4 M 0 10319 3.60 A 2701831 D Common Stock 2018-10-19 4 S 0 6100 52.96 D 2695731 D Common Stock 2018-10-19 4 S 0 6300 53.74 D 2689431 D Common Stock 2018-10-19 4 S 0 4700 54.78 D 2684731 D Common Stock 2018-10-19 4 S 0 1800 55.57 D 2682931 D Common Stock 2018-10-19 4 S 0 618 53.20 D 93258 I By Family Partnership Common Stock 2018-10-19 4 S 0 300 54.69 D 92958 I By Family Partnership Common Stock 19500 I By Spouse Common Stock 60946 I See footnote Stock Option (Right to Buy) 3.60 2018-10-18 4 M 0 10319 0.00 D 2019-03-11 Common Stock 10319 175423 D Stock Option (Right to Buy) 3.60 2018-10-19 4 M 0 10319 0.00 D 2019-03-11 Common Stock 10319 165104 D Shares sold pursuant to a 10b5-1 plan. The shares were sold at prices ranging from $53.73 to $54.71. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $54.765 to $55.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $53.90 to $54.77. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $55.26 to $55.31. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $52.305 to $53.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $53.31 to $54.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $54.31 to $55.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $55.31 to $55.77. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $52.90 to $53.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $54.15 to $55.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares are held by BioGrowth Partners, LP. The reporting person is the sole general partner of BioGrowth Partners, LP and has sole voting and dispositive power over the shares held by BioGrowth Partners, LP. Fully vested. /s/ Dorothy Pacini, Attorney-in-fact 2018-10-19